Grupo de Investigación Pharmananogene

• Isla A, Gascón AR, Trocóniz IF, Bueno L, Solinís MA, Maynar J, Sánchez-Izquierdo JA, Pedraz JL.  Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapies Clinical Pharmacokinetics,  2008;  47,  173 - 180
• Gascón AR, Pedraz JL.  Cationic lipids as gene transfer agents: a patent review Expert Opinion on Therapeutic Patents,  2008;  18,  515 - 524
• del Pozo-Rodríguez A, Delgado D, Solinís MA, Gascón AR, Pedraz JL.  Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells International Journal of Pharmaceutics,  2008;  360,  177 - 183
• Otaegui D, Rodríguez-Gascón A, Zubia A, Cossio FP, Pedraz JL.  Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: Application to a pharmacokinetic study Journal of Chromatography B,  2008;  287,  109 - 116